FREDERICK, Md., Dec. 22 /PRNewswire-FirstCall/ -- BioElectronics Corporation , announced today that the company has commenced shipment of the next-generation ActiPatch(TM) products for the plastic surgery markets.
“We are pleased to announce that our new product line is now available for plastic surgery providers. This new product is designed to work for specific procedures such as breast augmentation, liposuction, blepharoplasty and other popular plastic surgery procedures. We are pleased with the new product and look forward to providing these new designs to thousands of patients and providers worldwide,” said Thomas J. O’Connor, COO of BioElectronics Corporation.
“These new products will be available through our distribution partnership with Mentor Corporation and we are delighted that they continue to show such great support for our breakthrough technology,” continued O’Connor.
“We worked closely with providers in developing this solution for our customers and we are excited to present this new line. These new devices are not only more flexible, they are designed to cover specific areas of the body that require tailored sizes for maximum comfort and patient compliance,” said Joe Iglesias VP of Engineering Design for the company.
The new ActiPatch(TM) for plastic surgery products are available in four unique shapes tailored for specific applications. The products were designed in conjunction with leading plastic surgeons throughout the country. The same drug-free anti-inflammatory properties remain while the product is much thinner and more flexible in design, enabling ActiPatch to be embedded or used in conjunction with a wide range of therapeutic delivery systems.
ActiPatch(TM) is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch(TM) delivery system, using patented technology, provides a cost-effective, patient friendly method to resolve soft tissue injury.
For more information visit http://www.bioelectronicscorp.com
Safe Harbor Statement:
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
BioElectronics Corporation
CONTACT: Andrew J. Whelan, President & CEO, or Thomas O’Connor, EVP,Operations & COO, of BioElectronics Corporation, Phone: +1-301-644-3906,Fax: +1-301-644-3939, or info@bioelectronicscorp.com
Web site: http://www.bioelectronicscorp.com//
